Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

2,688 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 635
Recruiting: 365
Ph III recruiting: 20
Growth YoY: −15.2%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (367)

clinicaltrialsPublishedShowing 951–1,000 of 1,108 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00036712	Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation	unknown	Phase 2	80	Medical College of WisconsinOTHER	1	Sep 20, 2013	clinicaltrials
NCT00005066	O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma	completed	Phase 2	12	University of ChicagoOTHER	1	Sep 5, 2013